Cited by 1,586Tryptophan and brain disordersAmino Acid Enzymes and MetabolismCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 292 of the 292 references it cites were found in a registry or an index.

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

Open access

Platten, Michael, Nollen, Ellen A. A., Röhrig, Ute F., Fallarino, Francesca, Opitz, Christiane A.·2019·Nature Reviews Drug Discovery

DOI 10.1038/s41573-019-0016-5

Open this paper in CoChat — free account

Abstract

L-Tryptophan (Trp) metabolism through the kynurenine pathway (KP) is involved in the regulation of immunity, neuronal function and intestinal homeostasis. Imbalances in Trp metabolism in disorders ranging from cancer to neurodegenerative disease have stimulated interest in therapeutically targeting the KP, particularly the main rate-limiting enzymes indoleamine-2,3-dioxygenase 1 (IDO1), IDO2 and tryptophan-2,3-dioxygenase (TDO) as well as kynurenine monooxygenase (KMO). However, although small-molecule IDO1 inhibitors showed promise in early-stage cancer immunotherapy clinical trials, a phase III trial was negative. This Review summarizes the physiological and pathophysiological roles of Trp metabolism, highlighting the vast opportunities and challenges for drug development in multiple diseases.

Integrity signals

Registry

Crossref · 10.1038/s41573-019-0016-5

Cites

292 of 292 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Items 201–292 of 292

Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction.
Jensen, L. T., Hørslev-Petersen, K., Toft, P. B., Bentsen, K. D., Grande, P., Simonsen, E. E., & Lorenzen, I. (1990) · Circulation · doi:10.1161/01.cir.81.1.52 · Cited by 82
Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice
Larkin, P. B., Sathyasaikumar, K. V., Notarangelo, F. M., Funakoshi, H., Nakamura, T., Schwarcz, R. M., & Muchowski, P. J. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.07.002 · Cited by 82
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy
Zhai, L., Dey, M., Lauing, K. L., Gritsina, G., Kaur, R., Lukas, R. V., Nicholas, M. K., RADEMAKER, A. W., Dostal, C. R., McCusker, R. H., et al. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.06.018 · Cited by 81
Kynurenic Acid Is a Nutritional Cue that Enables Behavioral Plasticity
Lemieux, G. A., Cunningham, K. A., Lin, L., Mayer, F., Werb, Z., & Ashrafi, K. (2015) · Cell · doi:10.1016/j.cell.2014.12.028 · Cited by 80
Indoleamine 2,3-Dioxygenase Mediates Cell Type-Specific Anti-Measles Virus Activity of Gamma Interferon
Obojes, K., Andrés, O., Kim, K. S., Däubener, W., & Schneider‐Schaulies, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7768-7776.2005 · Cited by 80
Modulators of the Kynurenine Pathway of Tryptophan Metabolism: Synthesis and Preliminary Biological Evaluation of ( S )‐4‐(Ethylsulfonyl)benzoylalanine, a Potent and Selective Kynurenine Aminotransferase II (KAT II) Inhibitor
Pellicciari, R., Rizzo, R. C., Costantino, G., Marinozzi, M., Amori, L., Guidetti, P., Wu, H., & Schwarcz, R. M. (2006) · ChemMedChem · doi:10.1002/cmdc.200500095 · Cited by 78
The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine
Oxenkrug, G. F. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0341-7 · Cited by 77
How Does Indoleamine 2,3-Dioxygenase Contribute to HIV-Mediated Immune Dysregulation
Boasso, A., & Shearer, G. M. (2007) · Current Drug Metabolism · doi:10.2174/138920007780362527 · Cited by 75
Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls.
Holtze, M., Saetre, P., Engberg, G., Schwieler, L., Werge, T., Andreassen, O., Hall, H., Terenius, L., Agartz, I., Jönsson, E. G., et al. (2012) · Journal of Psychiatry & Neuroscience · doi:10.1503/jpn.100175 · Cited by 75
Clinical-Grade Multipotent Adult Progenitor Cells Durably Control Pathogenic T Cell Responses in Human Models of Transplantation and Autoimmunity
Reading, J. L., Yang, J. H. M., Sabbah, S., Skowera, A., Knight, R. R., Pinxteren, J., Vaes, B. L. T., Allsopp, T. E., Ting, A. E., Busch, S. A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202710 · Cited by 68
Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease
Toledo, L. M., Prime, M. E., Mrzljak, L., Beconi, M. G., Beresford, A. P., Brookfield, F. A., Brown, C. J., Cardaun, I., Courtney, S. M., Dijkman, U., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501350y · Cited by 67
The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis
Inglis, J. J., Criado, G., Andrews, M. R., Feldmann, M., Williams, R. O., & Selley, M. L. (2007) · Rheumatology · doi:10.1093/rheumatology/kem160 · Cited by 67
Kynurenine Aminotransferase Isozyme Inhibitors: A Review
Nematollahi, A., Sun, G., Jayawickrama, G. S., & Church, W. B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060946 · Cited by 67
Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3‐Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon‐Positive Primary Sjögren's Syndrome
Maria, N. I., van Helden-Meeuwsen, C. G., Brkić, Z., Paulissen, S. M. J., Steenwijk, E. C., Dalm, V. A. S. H., van Daele, P. L. A., van Hagen, P. M., Kroese, F. G. M., van Roon, J. A. G., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39629 · Cited by 66
P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer
Tang, D., Yue, L., Yao, R., Zhou, L., Yang, Y., Lu, L., & Gao, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17408 · Cited by 66
Utilization of tryptophan, nicotinamide and nicotinic acid as precursors for nicotinamide nucleotide synthesis in isolated rat liver cells
Bender, D. A., & Olufunwa, R. (1988) · British Journal Of Nutrition · doi:10.1079/bjn19880035 · Cited by 64
The stress kinase GCN2 does not mediate suppression of antitumor T cell responses by tryptophan catabolism in experimental melanomas
Sonner, J. K., Deumelandt, K., Ott, M., Thomé, C. M., Rauschenbach, K. J., Schulz, S., Munteanu, B., Mohapatra, S., Adam, I., Hofer, A.-C., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1240858 · Cited by 64
Self-citation
Forced IDO 1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes
Pallotta, M. T., Orabona, C., Bianchi, R., Vacca, C., Fallarino, F., Belladonna, M. L., Volpi, C., Mondanelli, G., Gargaro, M., Allegrucci, M., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12360 · Cited by 63
Self-citation
Inhibition of Indoleamine 2,3-Dioxygenase Activity by Levo-1-Methyl Tryptophan Blocks Gamma Interferon-Induced Chlamydia trachomatis Persistence in Human Epithelial Cells
Ibana, J. A., Belland, R. J., Zea, A. H., Schust, D. J., Nagamatsu, T., AbdelRahman, Y. M., Tate, D. J., Beatty, W. L., Aiyar, A. A., & Quayle, A. J. (2011) · Infection and Immunity · doi:10.1128/iai.05659-11 · Cited by 63
Comparison of New Tau PET-Tracer Candidates With [ 18 F]T808 and [ 18 F]T807
Declercq, L., Celen, S., Lecina, J., Ahamed, M., Tousseyn, T., Moechars, D., Alcázar, J., Ariza, M., Fierens, K., Bottelbergs, A., et al. (2016) · Molecular Imaging · doi:10.1177/1536012115624920 · Cited by 63
IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients
Wang, W., Huang, L., Jin, J., Jolly, S., Zang, Y., Wu, H., Yan, L., Pi, W., Li, L., Mellor, A. L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2995 · Cited by 63
A new cancer immunotherapy suffers a setback
Garber, K. (2018) · Science · doi:10.1126/science.360.6389.588 · Cited by 63
Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti, R. M., Maloney, E. M., Hanchard, B., Morgan, O., Steinberg, S. M., WACHTER, H., Williams, E., Cranston, B., Fuchs, D., & Manns, A. (1996) · PubMed · Cited by 61
The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease
Beaumont, V., Mrzljak, L., Dijkman, U., Freije, R., Heins, M., Rassoulpour, A., Tombaugh, G. C., Gelman, S., Bradaïa, A., Steidl, E., et al. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.005 · Cited by 61
Extension of life span of Drosophila melanogaster by the inhibitors of tryptophan-kynurenine metabolism
Oxenkrug, G. F., Navrotskaya, V., Voroboyva, L., & D, P. S. M. (2011) · Fly · doi:10.4161/fly.5.4.18414 · Cited by 60
Induction and Role of Indoleamine 2,3 Dioxygenase in Mouse Models of Influenza A Virus Infection
Huang, L., Li, L., Klonowski, K., Tompkins, S. M., Tripp, R. A., & Mellor, A. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066546 · Cited by 59
Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway
Ott, M., Litzenburger, U. M., Rauschenbach, K. J., Bunse, L., Ochs, K., Sahm, F., Pusch, S., Opitz, C. A., Blaes, J., von Deimling, A., et al. (2014) · Glia · doi:10.1002/glia.22734 · Cited by 59
Self-citation
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice
Fazio, F., Zappulla, C., Notartomaso, S., Busceti, C. L., Bessede, A., Scarselli, P., Vacca, C., Gargaro, M., Volpi, C., Allegrucci, M., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.011 · Cited by 58
Self-citation
Dynamics of NAD-metabolism: everything but constant
Opitz, C. A., & Heiland, I. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150133 · Cited by 58
Self-citation
Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure ― Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) ―
Konishi, M., Ebner, N., Springer, J., Schefold, J. C., Doehner, W., Dschietzig, T. B., Anker, S. D., & von Haehling, S. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0791 · Cited by 58
Caenorhabditis elegans orthologs of human genes differentially expressed with age are enriched for determinants of longevity
Sutphin, G. L., Backer, G., Sheehan, S., Bean, S., Corban, C., Liu, T., Peters, M. J., van Meurs, J. B. J., Murabito, J. M., Johnson, A. D., et al. (2017) · Aging Cell · doi:10.1111/acel.12595 · Cited by 58
Induction of Indoleamine 2,3-Dioxygenase by Uropathogenic Bacteria Attenuates Innate Responses to Epithelial Infection
Loughman, J. A., & Hunstad, D. A. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis280 · Cited by 57
Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis
Lanz, T. V., Williams, S. K., Stojic, A., Iwantscheff, S., Sonner, J. K., Grabitz, C., Becker, S., Böhler, L.-I., Mohapatra, S. R., Sahm, F., et al. (2017) · Scientific Reports · doi:10.1038/srep41271 · Cited by 56
Self-citation
Tryptophan‐2,3‐dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor‐4
Ochs, K., Ott, M., Rauschenbach, K. J., Deumelandt, K., Sahm, F., Opitz, C. A., von Deimling, A., Wick, W., & Platten, M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13503 · Cited by 55
Self-citation
Xanthurenic Acid Formation from 3-Hydroxykynurenine in the Mammalian Brain: Neurochemical Characterization and Physiological Effects
Sathyasaikumar, K. V., Tararina, M. A., Wu, H., Neale, S. A., Weisz, F., Salt, T. E., & Schwarcz, R. M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.10.006 · Cited by 55
Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1.
Hissong, B., Byrne, G. I., Padilla, M., & Carlin, J. M. (1995) · Cellular Immunology · doi:10.1016/0008-8749(95)80037-j · Cited by 53
Crystal Structure-Based Selective Targeting of the Pyridoxal 5′-Phosphate Dependent Enzyme Kynurenine Aminotransferase II for Cognitive Enhancement
Rossi, F., Casazza, V., Garavaglia, S., Sathyasaikumar, K. V., Schwarcz, R. M., Kojima, S., Okuwaki, K., Ono, S.-I., Kajii, Y., & Rizzi, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100464k · Cited by 53
Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin
Vareki, S. M., Rytelewski, M., Figueredo, R., Chen, D., Ferguson, P. J., Vincent, M. D., Min, W., Zheng, X., & Koropatnick, J. D. (2014) · Oncotarget · doi:10.18632/oncotarget.1916 · Cited by 53
Mouse Mesenchymal Stem Cells Suppress Antigen-Specific TH Cell Immunity Independent of Indoleamine 2,3-Dioxygenase 1 (IDO1)
Lanz, T. V., Opitz, C. A., Ho, P. P.-K., Agrawal, A., Lutz, C., Weller, M., Mellor, A. L., Steinman, L., Wick, W., & Platten, M. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0385 · Cited by 52
Self-citation
Interferon: a mediator of indoleamine 2,3-dioxygenase induction by lipopolysaccharide, poly(I) X poly(C), and pokeweed mitogen in mouse lung.
Yoshida, R., Oku, T., Imanishi, J., Kishida, T., & Hayaisi, O. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90038-x · Cited by 51
Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase
Hutchinson, J. P., Rowland, P., Taylor, M. R. D., Christodoulou, E., Haslam, C. P., Hobbs, C. I., Holmes, D. S., Homes, P., Liddle, J., Mole, D. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15827 · Cited by 51
IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity
Merlo, L. M. F., & Mandik‐Nayak, L. (2016) · Clinical Medicine Insights Pathology · doi:10.4137/cpath.s39930 · Cited by 50
Frailty Status in Older Adults Is Related to Alterations in Indoleamine 2,3-Dioxygenase 1 and Guanosine Triphosphate Cyclohydrolase I Enzymatic Pathways
Marcos-Pérez, D., Sánchez-Flores, M., Maseda, A., Lorenzo‐López, L., Millán-Calentí, J. C., Strasser, B., Gostner, J. M., Fuchs, D., Pásaro, E., Valdiglesias, V., et al. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.06.021 · Cited by 50
Immunological and Nonimmunological Effects of Indoleamine 2,3-Dioxygenase on Breast Tumor Growth and Spontaneous Metastasis Formation
Levina, V. V., Su, Y., & Gorelik, E. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/173029 · Cited by 49
Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis
Merlo, L. M. F., Grabler, S., DuHadaway, J. B., Pigott, E., Manley, K., Prendergast, G. C., Laury‐Kleintop, L. D., & Mandik‐Nayak, L. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.01.016 · Cited by 48
Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra
Knyihár‐Csillik, E., Chadaide, Z., Mihály, A., Krisztin‐Péva, B., Fenyö, R., & Vécsei, L. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0086-4 · Cited by 47
Association study between kynurenine 3‐monooxygenase gene and schizophrenia in the Japanese population
Aoyama, N., Takahashi, N., Saito, S., Maeno, N., Ishihara, R., Ji, X., Miura, H., Ikeda, M., Suzuki, T., Kitajima, T., et al. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00231.x · Cited by 46
Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration
Liu, X.-Q., Lu, K., Feng, L., Ding, M., Gao, J., Ge, X., & Wang, X. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.804917 · Cited by 45
Suppression of Th1 differentiation by tryptophan supplementation in vivo
Lanz, T. V., Becker, S., Mohapatra, S. R., Opitz, C. A., Wick, W., & Platten, M. (2017) · Amino Acids · doi:10.1007/s00726-017-2415-4 · Cited by 45
Self-citation
The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia
Iaccarino, H. F., Suckow, R. F., Xie, S., & Bucci, D. J. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.09.004 · Cited by 44
Role of Indoleamine 2,3-Dioxygenase in Antiviral Activity of Interferon-γ Against Vaccinia Virus
Terajima, M., & Leporati, A. (2005) · Viral immunology · doi:10.1089/vim.2005.18.722 · Cited by 43
1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2)
Röhrig, U. F., Majjigapu, S. R., Caldelari, D., Dilek, N., Reichenbach, P., Ascenção, K., Irving, M. B., Coukos, G., Vogel, P., Zoete, V., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.031 · Cited by 42
Self-citation
The Effects of an inhibitor of tryptophan 2,3-dioxygenase and a combined inhibitor of tryptophan 2,3-dioxygenase and 5-HT reuptake in the rat
Salter, M., Hazelwood, R., Pogson, C. I., Iyer, R. N., Madge, D. J., Jones, H. T., Cooper, B. R., Cox, R. F., Wang, C. M., & Wiard, R. P. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00147-k · Cited by 41
Inhibition of indoleamine 2,3-dioxygenase activity in IFN-γ stimulated astroglioma cells decreases intracellular NAD levels
Grant, R., & Kapoor, V. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00464-7 · Cited by 40
Suicidality and Activation of the Kynurenine Pathway of Tryptophan Metabolism
Bryleva, E. Y., & Brundin, L. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_5 · Cited by 40
Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer
Dewi, D. L., Mohapatra, S. R., Blanco, S., Adam, I., Patterson, L. F. S., Berdel, B., Kahloon, M., Thürmann, L., Loth, S., Heilmann, K., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1274477 · Cited by 40
Self-citation
Efficient tryptophan‐catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes
Yuasa, H. J., & Ball, H. J. (2015) · Journal of Experimental Zoology Part B Molecular and Developmental Evolution · doi:10.1002/jez.b.22608 · Cited by 39
High-Throughput Fluorescence-Based Screening Assays for Tryptophan-Catabolizing Enzymes
Willemsen‐Seegers, N., van Doornmalen, A. M., Uitdehaag, J. C. M., de Man, J., Buijsman, R. C., & Zaman, G. J. R. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114536616 · Cited by 39
Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors
Li, J., Li, Y., Yang, D., Hu, N., Zhanling, G., Kuang, C., & Yang, Q. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.013 · Cited by 38
Metabolism and Pharmacokinetics of JM6 in Mice: JM6 Is Not a Prodrug for Ro-61-8048
Beconi, M. G., Yates, D., Lyons, K. A., Matthews, K. L., Clifton, S., Mead, T. L., Prime, M. E., Winkler, D. F. H., O'Connell, C., Walter, D. S., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046532 · Cited by 36
Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma
Guastella, A. R., Michelhaugh, S. K., Klinger, N. V., Kupsky, W. J., Polin, L., Muzik, O., Juhász, C., & Mittal, S. (2016) · Molecular Imaging · doi:10.1177/1536012116644881 · Cited by 36
Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis
Walker, A. L., Ancellin, N., Beaufils, B., Bergeal, M., Binnie, M., Bouillot, A., Clapham, D., Denis, A., Haslam, C. P., Holmes, D. S., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00055 · Cited by 36
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes
Mondanelli, G., Albini, E., Pallotta, M. T., Volpi, C., Chatenoud, L., Kuhn, C., Fallarino, F., Matino, D., Belladonna, M. L., Bianchi, R., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00428 · Cited by 36
Self-citation
Structural Basis for Inhibitor-Induced Hydrogen Peroxide Production by Kynurenine 3-Monooxygenase
Kim, H. T., Na, B. K., Chung, J., Kim, S., Kwon, S. K., Cha, H., Son, J., Cho, J. M., & Hwang, K. Y. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.01.008 · Cited by 36
Modulation of the Kynurine Pathway of Tryptophan Metabolism in Search for Neuroprotective Agents. Focus on Kynurenine-3-Hydroxylase
Pellicciari, R., Amori, L., Costantino, G., Giordani, A., Macchiarulo, A., Mattoli, L., Pevarello, P., Speciale, C., & Varasi, M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_71 · Cited by 35
IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype
Lee, A., Kanuri, N. D., Zhang, Y., Sayuk, G. S., Li, E., & Ciorba, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115848 · Cited by 35
Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood
DeAngeli, N. E., Todd, T. P., Chang, S. E., Yeh, H. H., Yeh, P. W. L., & Bucci, D. J. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00451 · Cited by 35
Chemical Inhibition of Kynureninase Reduces Pseudomonas aeruginosa Quorum Sensing and Virulence Factor Expression
Kasper, S. H., Bonocora, R. P., Wade, J. T., Musah, R. A., & Cady, N. C. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01082 · Cited by 35
Tryptophan metabolites interfere with the Ehrlich reaction used for the measurement of kynurenine
Alegre, E., López, A. S., & González, Á. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.11.005 · Cited by 34
Microenvironment Tumor Metabolic Interactions Highlighted by qMSI: Application to the Tryptophan-Kynurenine Pathway in Immuno-Oncology
Ait-Belkacem, R., Bol, V., Hamm, G. R., Schramme, F., den Eynde, B. J. V., Poncelet, L., Pamelard, F., Stauber, J., & Gomes, B. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217712659 · Cited by 34
In Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines
Hippen, K. L., O’Connor, R. S., Lemire, A. M., Saha, A., Hanse, E. A., Tennis, N. C., Merkel, S. C., Kelekar, A., Riley, J. L., Levine, B. L., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14338 · Cited by 33
IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive
Godin-Ethier, J., Hanafi, L., Duvignaud, J., Leclerc, D., & Lapointe, R. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.08.017 · Cited by 32
Sequence Variants in Kynurenine Aminotransferase II (KAT II) Orthologs Determine Different Potencies of the Inhibitor S‐ESBA
Pellicciari, R., Venturoni, F., Bellocchi, D., Carotti, A., Marinozzi, M., Macchiarulo, A., Amori, L., & Schwarcz, R. M. (2008) · ChemMedChem · doi:10.1002/cmdc.200800109 · Cited by 30
Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity
Kegel, M. E., Johansson, V., Wetterberg, L., Bhat, M., Schwieler, L., Cannon, T. D., Schuppe‐Koistinen, I., Engberg, G., Landén, M., Hultman, C. M., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.11.017 · Cited by 29
Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas
Maliniemi, P., Laukkanen, K., Väkevä, L. H., Dettmer, K., Lipsanen, T., Jeskanen, L., Bessede, A., Oefner, P. J., Kadin, M. E., & Ranki, A. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1273310 · Cited by 29
Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma
Bosnyák, E., Michelhaugh, S. K., Klinger, N. V., Kamson, D. O., Barger, G. R., Mittal, S., & Juhász, C. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001577 · Cited by 29
Abstract LB-085: RG70099: A novel, highly potent dual IDO1/TDO inhibitor to reverse metabolic suppression of immune cells in the tumor micro-environment
Gyülvészi, G., Fischer, C., Mirolo, M., Stern, M., Green, L., Ceppi, M., Wang, H., Bürgi, B., Staempfli, A. A., Muster, W., et al. (2016) · Cancer Research · doi:10.1158/1538-7445.am2016-lb-085 · Cited by 26
Xanthurenic acid is localized in neurons in the central nervous system
Roussel, G., Bessede, A., Klein, C., Maître, M., & Mensah‐Nyagan, A. G. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.006 · Cited by 22
Indoleamine 2,3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis
Asghar, K., Ashiq, M., Zulfiqar, B., Mahroo, A., Nasir, K., & Murad, S. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2146 · Cited by 21
Formation of an N-formylkynurenine-derived fluorophore and its use for measuring indoleamine 2,3-dioxygenase 1 activity
Tomek, P., Palmer, B. D., Flanagan, J. U., Fung, S.-P. S., Bridewell, D. J. A., Jamie, J. F., & Ching, L. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6650-y · Cited by 21
Kynurenines, Gender and Neuroinflammation; Showcase Schizophrenia
de Bie, J., Lim, C. K., & Guillemin, G. J. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9641-5 · Cited by 21
Production of Quinolinic Acid and Kynurenic Acid by Human Glioma
Vezzani, A., Gramsbergen, J. B., Speciale, C., & Schwarcz, R. M. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5952-4_95 · Cited by 20
Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences
Davar, D., & Bahary, N. (2018) · Targeted Oncology · doi:10.1007/s11523-017-0547-9 · Cited by 20
Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction
Vavrincová-Yaghi, D., Deelman, L. E., van Goor, H., Seelen, M. A., Vavrinec, P., Kema, I. P., Gomolcak, P., Benigni, A., Henning, R. H., & Sandovici, M. (2016) · Gene Therapy · doi:10.1038/gt.2016.59 · Cited by 18
Learning from other diseases: protection and pathology in chronic fungal infections
Zelante, T., Pieraccini, G., Scaringi, L., Aversa, F., & Romani, L. R. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0523-3 · Cited by 17
Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes
Jalili, R. B., Zhang, Y., Hosseini‐Tabatabaei, A., Kilani, R. T., Maharlooei, M. K., Li, Y., Elizei, S. S., Warnock, G. L., & Ghahary, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146970 · Cited by 16
Abstract 1701: EPL-1410, a novel fused heterocycle based orally active dual inhibitor of IDO1/TDO2, as a potential immune-oncology therapeutic
Gullapalli, S., Roychowdhury, A., Khaladkar, T. P., Sawargave, S., Janrao, R. A., Kalhapure, V., Urunkar, G., Kulathingal, J., Lekkala, R. R., Bhadra, S., et al. (2018) · Cancer Research · doi:10.1158/1538-7445.am2018-1701 · Cited by 16
Kynurenine Pathway Metabolism is Involved in the Maintenance of the Intracellular NAD + Concentration in Human Primary Astrocytes
Grant, R., Nguyen, S., & Guillemin, G. J. (2010) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s4779 · Cited by 15
The Janus-Faced Nature of Ido1 in Infectious Diseases: Challenges and Therapeutic Opportunities
Greco, F. A., Coletti, A., Camaioni, E., Carotti, A., Marinozzi, M., Gioiello, A., & Macchiarulo, A. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.165 · Cited by 14
Central Nervous System Infection with Borna Disease Virus Causes Kynurenine Pathway Dysregulation and Neurotoxic Quinolinic Acid Production
Formisano, S., Hornig, M., Yaddanapudi, K., Vasishtha, M., Parsons, L., Briese, T., Lipkin, W., & Williams, B. L. (2017) · Journal of Virology · doi:10.1128/jvi.00673-17 · Cited by 13
Indoleamine-2,3-dioxygenase(IDO)2 polymorphisms are not associated with multiple sclerosis in Italians
Agliardi, C., Guerini, F. R., Zanzottera, M., Rovaris, M., Caputo, D., & Clerici, M. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.048 · Cited by 11
Pre-Interventional Kynurenine Predicts Medium-Term Outcome after Contrast Media Exposure Due to Coronary Angiography
Reichetzeder, C., Heunisch, F., von Einem, G. F., Tsuprykov, O., Kellner, K.-H., Dschietzig, T. B., Kretschmer, A., & Hocher, B. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000477222 · Cited by 10

Sorted by citations

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Veglia, F., Sanseviero, E., & Gabrilovich, D. I. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00490-y · Cited by 1,940
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Self-citation
Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
Bader, J. E., Voss, K., & Rathmell, J. C. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.034 · Cited by 1,055
T cells in health and disease
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,153

See all 1,586

Authors: Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A.
Affiliations: German Cancer Research Center (DE)
University Medical Center Groningen (NL)
SIB Swiss Institute of Bioinformatics (CH)
University of Perugia (IT)
Corresponding author: Platten, Michael
ORCID: Platten, Michael
Nollen, Ellen A. A.
Röhrig, Ute F.
Fallarino, Francesca
Opitz, Christiane A.
Venue: Nature Reviews Drug Discovery
Publisher: Springer Science and Business Media LLC
Published: 2019-02-13
Volume: 18
Issue: 5
Pages: 379-401
ISSN: 1474-1776 (ISSN-L)
1474-1784
DOI: 10.1038/s41573-019-0016-5
OpenAlex: W2912181843
Cited by: 1,586
References: 292
Citations by year: 2026: 245 · 2025: 278 · 2024: 284 · 2023: 241 · 2022: 220 · 2021: 176 · 2020: 119 · 2019: 23
FWCI: 8.66
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Drug Discovery (publishedVersion)
PubMed (publishedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
Topics: Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: tryptophan metabolism, kynurenine pathway, IDO1 inhibitors, indoleamine 2,3-dioxygenase, IDO2, tryptophan 2,3-dioxygenase, kynurenine monooxygenase, cancer immunotherapy, neurodegeneration, autoimmune disease, infectious diseases, central nervous system disorders, drug development
MeSH terms: Animals, Antineoplastic Agents, Clinical Trials as Topic, Humans, Neoplasms, Tryptophan, Neurodegenerative Diseases, Metabolic Networks and Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks